No Controversy Here
While controversy exists in the USA concerning research with embryonic stem cells, everyone agrees that using adult stem cells are appropriate and efficacious. Rabin Medical Center has made a major breakthrough in applying adult stem cells to treat Parkinson's disease by developing NurOwn, a technology that generates neuron-like cells derived from human bone marrow. Using the patient's own bone marrow to supply dopamineproducing cells circumvents problems of immunity and compatibility. Credit for the discovery goes to Prof. Eldad Melamed, Director of Neurology at the Rabin Medical Center and member of the Michael J. Fox Foundation for Parkinson's Research, together with Dr. Daniel Offen, Director of Laboratory of Neurosciences at Rabin Medical Center, and Dr. Yosef Levy. Commercialized by Brainstorm Cell Therapeutics based in Tel Aviv, NurOwn actually produces the missing chemical that enables restoration of motor movement.
Related Articles
The Earlier the Better: Probing Malignancies in Newborns
Building on their established international partnership, GE
Healthcare and Rabin Medical Center are developing innovative
products and working on creative medical solutions to facilitate
the early diagnosis of medical problems in pregnant women
and their fetuses.
Israeli Researchers Identify Protein that Protects Brain Cells from Parkinson's
The protein, called NID-13, has proven effective in lab mice; researchers have registered a patent.
Revolutionary Technology for Cardiac Patients
For the first time in Israel, at the Catheterization Institute at Rabin Medical Center, a revolutionary heart catheterization procedure was performed using soluble stents.